Rchr
J-GLOBAL ID：201801007406874632   Update date: Jun. 30, 2025

Akita Hirofumi

アキタ ヒロフミ | Akita Hirofumi
Affiliation and department：
-

About -


Other affiliations (1)：
  • 国立研究開発法人医薬基盤・健康・栄養研究所  協力研究員
Research field  (1)： Digestive surgery
Research theme for competitive and other funds  (18)：
  • 2025 - 2028 門脈血エクソソーム内microRNAを介した膵癌肝・肺転移の分子メカニズム解明
  • 2023 - 2026 膵癌における臨床応用を見据えた高次免疫学的解析手法を駆使した免疫微小環境の解析
  • 2022 - 2025 末梢血・門脈血中microRNA解析による臓器別転移機序の解明と個別化治療の開発
  • 2019 - 2022 The cellular senescence of cancer-associated fibroblast affect the malignant potential in pancreatic cancer
  • 2017 - 2019 Establishment of Highly Intrahepatic Metastatic Cell Line of HCC by In Vivo Selection and Investigation of Mechanism by Integrated Microarray Analysis
Show all
Papers (509)：
  • Shinichiro Hasegawa, Hiroshi Wada, Masahiko Kubo, Yosuke Mukai, Manabu Mikamori, Hirofumi Akita, Norihiro Matsuura, Masatoshi Kitakaze, Yasunori Masuike, Takahito Sugase, et al. The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy. Langenbeck's archives of surgery. 2024. 409. 1. 302-302
  • 青山 修宇, 阪野 佳弘, 的羽 大二朗, 野田 剛広, 小林 省吾, 佐々木 一樹, 長谷川 慎一郎, 岩上 佳史, 山田 大作, 富丸 慶人, et al. 大腸癌肝転移におけるribosomal protein S15発現の臨床的意義. 日本癌治療学会学術集会抄録集. 2024. 62回. P80-1
  • Hirofumi Akita, Yosuke Mukai, Masahiko Kubo, Hidenori Takahashi, Shinichiro Hasegawa, Masatoshi Kitakaze, Norihiro Matsuura, Yasunori Masuike, Takahito Sugase, Naoki Shinno, et al. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer. Surgery. 2024. 176. 4. 1215-1221
  • 和田 浩志, 長谷川 慎一郎, 秋田 裕史, 網崎 正孝, 久保 維彦, 向井 洋介, 小松 久晃, 後藤 邦仁. 切除不能胆道癌に対するConversion Surgeryの治療成績. 胆道. 2024. 38. 3. 459-459
  • Takahito Sugase, Takashi Kanemura, Tomohira Takeoka, Norihiro Matsuura, Yasunori Masuike, Naoki Shinno, Hisashi Hara, Masatoshi Kitakaze, Masahiko Kubo, Yosuke Mukai, et al. Survival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus Chemotherapy. Journal of immunotherapy (Hagerstown, Md. : 1997). 2024. 47. 7. 249-257
ｍore...
MISC (85)：
ｍore...
Education (2)：
  • 2006 - 2010 Osaka University Graduate School of Medicine Department of Surgery
  • 1995 - 2001 Osaka University Medicine Medicine
Professional career (1)：
  • 医学博士 (大阪大学大学院)
Work history (10)：
  • 2018/04 - 現在 Osaka University Graduate School of Medicine Department of Gastroenterological Surgery assistant professor
  • 2017/04 - 2018/03 Osaka International Cancer Institute Department of Gastroenterological Surgery Staff
  • 2014/04 - 2017/03 Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Surgery staff
  • 2013/04 - 2014/03 Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Gastroenterological Surgery Staff
  • 2012/04 - 2013/03 Osaka University Graduate School of Medicine Department of Surgery extraordinary assistant professor
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM